The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a effective tool in everyday clinical practice for the identification of cognitive impairment (CI) in patients with MS, an Italian study has confirmed.
The study also highlighted the good psychometric properties of the symbol digit modalities test (SDMT), Maria P. Amato, MD, of the University of Florence, Italy,
“It seems important to stress that, in optimal clinical conditions, where a neuropsychologist can take care of the cognitive assessment, it is preferable to
The study showed that when BICAMS was compared with other commonly used neuropsychological batteries used in MS, such as the Brief Repeatable Battery (BRB), neither BICAMS nor BRB were equivalent to SDMT in the assessment of CI in MS. This is in keeping with the recent literature, pointed out the investigators.
“On the basis of our results, the agreement between the BICAMS and the BRB is fair